Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Opens Biomarker Discovery Center

Premium

Ciphergen Biosystems has opened its first biomarker discovery center in Palo Alto, Calif., dedicated to proteomics research and protein biomarker discovery including differential protein expression, protein characterization, assay development and validation, and protein interaction studies.

The studies will use Ciphergen’s ProteinChip System and Arrays.

The BDC hopes to forge corporate and customer relationships to discover, characterize, and validate novel protein biomarkers from biological samples provided by Ciphergen’s collaborators.

Protein biomarkers can be used to identify disease prior to the appearance of physical symptoms, as well as identify new disease pathways and drug targets, the company said.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.